This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sanofi. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Mike Helms - Innovator in RNA Therapeutics
Introduction
Mike Helms is a prominent inventor based in Frankfurt, Germany. He has made significant contributions to the field of RNA therapeutics, particularly in the area of gene expression regulation. His innovative work has the potential to impact various medical conditions associated with ANGPTL8 gene expression.
Latest Patents
Mike Helms holds 1 patent related to RNA compositions and methods for inhibiting ANGPTL8. This patent focuses on double-stranded RNAs (dsRNAs) that target ANGPTL8, outlining methods for inhibiting its gene expression. The implications of this work are substantial, as it offers new avenues for treating conditions linked to ANGPTL8.
Career Highlights
Mike Helms is currently employed at Sanofi, a global healthcare company known for its commitment to innovation in pharmaceuticals. His role at Sanofi allows him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Armin Hofmeister and Kerstin Jahn-Hofmann. Their collaborative efforts enhance the research environment and foster innovation within the team.
Conclusion
Mike Helms is a dedicated inventor whose work in RNA therapeutics is paving the way for new treatment options. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.